These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20851743)

  • 1. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain.
    Mantyh WG; Jimenez-Andrade JM; Stake JI; Bloom AP; Kaczmarska MJ; Taylor RN; Freeman KT; Ghilardi JR; Kuskowski MA; Mantyh PW
    Neuroscience; 2010 Dec; 171(2):588-98. PubMed ID: 20851743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.
    Jimenez-Andrade JM; Ghilardi JR; Castañeda-Corral G; Kuskowski MA; Mantyh PW
    Pain; 2011 Nov; 152(11):2564-2574. PubMed ID: 21907491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain.
    Ghilardi JR; Freeman KT; Jimenez-Andrade JM; Mantyh WG; Bloom AP; Kuskowski MA; Mantyh PW
    Mol Pain; 2010 Dec; 6():87. PubMed ID: 21138586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain.
    Jimenez-Andrade JM; Bloom AP; Stake JI; Mantyh WG; Taylor RN; Freeman KT; Ghilardi JR; Kuskowski MA; Mantyh PW
    J Neurosci; 2010 Nov; 30(44):14649-56. PubMed ID: 21048122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers.
    Bloom AP; Jimenez-Andrade JM; Taylor RN; Castañeda-Corral G; Kaczmarska MJ; Freeman KT; Coughlin KA; Ghilardi JR; Kuskowski MA; Mantyh PW
    J Pain; 2011 Jun; 12(6):698-711. PubMed ID: 21497141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
    Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
    Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice.
    Jimenez-Andrade JM; Mantyh PW
    Arthritis Res Ther; 2012 May; 14(3):R101. PubMed ID: 22548760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGF blockade at early times during bone cancer development attenuates bone destruction and increases limb use.
    McCaffrey G; Thompson ML; Majuta L; Fealk MN; Chartier S; Longo G; Mantyh PW
    Cancer Res; 2014 Dec; 74(23):7014-23. PubMed ID: 25287160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain.
    Chartier SR; Thompson ML; Longo G; Fealk MN; Majuta LA; Mantyh PW
    Pain; 2014 Nov; 155(11):2323-36. PubMed ID: 25196264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone.
    Chapurlat RD; Gensburger D; Jimenez-Andrade JM; Ghilardi JR; Kelly M; Mantyh P
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S3. PubMed ID: 22640953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers.
    Ghilardi JR; Freeman KT; Jimenez-Andrade JM; Mantyh WG; Bloom AP; Bouhana KS; Trollinger D; Winkler J; Lee P; Andrews SW; Kuskowski MA; Mantyh PW
    Bone; 2011 Feb; 48(2):389-98. PubMed ID: 20854944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization.
    Sevcik MA; Ghilardi JR; Peters CM; Lindsay TH; Halvorson KG; Jonas BM; Kubota K; Kuskowski MA; Boustany L; Shelton DL; Mantyh PW
    Pain; 2005 May; 115(1-2):128-41. PubMed ID: 15836976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of nerve growth factor by murine smooth muscle cells: role of the p75 neurotrophin receptor on sympathetic and sensory sprouting.
    Petrie CN; Smithson LJ; Crotty AM; Michalski B; Fahnestock M; Kawaja MD
    J Comp Neurol; 2013 Aug; 521(11):2621-43. PubMed ID: 23322532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture.
    Jimenez-Andrade JM; Martin CD; Koewler NJ; Freeman KT; Sullivan LJ; Halvorson KG; Barthold CM; Peters CM; Buus RJ; Ghilardi JR; Lewis JL; Kuskowski MA; Mantyh PW
    Pain; 2007 Dec; 133(1-3):183-96. PubMed ID: 17693023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting nerve growth factor in pain: what is the therapeutic potential?
    Watson JJ; Allen SJ; Dawbarn D
    BioDrugs; 2008; 22(6):349-59. PubMed ID: 18998753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A.
    Castañeda-Corral G; Jimenez-Andrade JM; Bloom AP; Taylor RN; Mantyh WG; Kaczmarska MJ; Ghilardi JR; Mantyh PW
    Neuroscience; 2011 Mar; 178():196-207. PubMed ID: 21277945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia.
    Nauta HJ; Wehman JC; Koliatsos VE; Terrell MA; Chung K
    J Neurosurg; 1999 Sep; 91(3):447-53. PubMed ID: 10470820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone cancer pain: causes, consequences, and therapeutic opportunities.
    Mantyh P
    Pain; 2013 Dec; 154 Suppl 1():S54-S62. PubMed ID: 23916671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur.
    Koewler NJ; Freeman KT; Buus RJ; Herrera MB; Jimenez-Andrade JM; Ghilardi JR; Peters CM; Sullivan LJ; Kuskowski MA; Lewis JL; Mantyh PW
    J Bone Miner Res; 2007 Nov; 22(11):1732-42. PubMed ID: 17638576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor.
    Eibl JK; Strasser BC; Ross GM
    Neurochem Int; 2012 Dec; 61(8):1266-75. PubMed ID: 23103525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.